602 related articles for article (PubMed ID: 33647547)
21. SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities.
Johnston EE; Martinez I; Davis ES; Caudill C; Richman J; Brackett J; Dickens DS; Kahn A; Schwalm C; Sharma A; Patel PA; Bhatia S; Levine JM; Wolfson JA;
J Clin Oncol; 2021 Dec; 39(34):3778-3788. PubMed ID: 34694886
[TBL] [Abstract][Full Text] [Related]
22. Examining potential Long COVID effects through utilization of healthcare resources: a retrospective, population-based, matched cohort study comparing individuals with and without prior SARS-CoV-2 infection.
Castriotta L; Onder G; Rosolen V; Beorchia Y; Fanizza C; Bellini B; Floridia M; Giuliano M; Silenzi A; Pricci F; Grisetti T; Grassi T; Tiple D; Villa M; Profili F; Francesconi P; Barbone F; Bisceglia L; Brusaferro S
Eur J Public Health; 2024 Jun; 34(3):592-599. PubMed ID: 38243748
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE).
Castelo-Branco L; Tsourti Z; Gennatas S; Rogado J; Sekacheva M; Viñal D; Lee R; Croitoru A; Vitorino M; Khallaf S; Šušnjar S; Soewoto W; Cardeña A; Djerouni M; Rossi M; Alonso-Gordoa T; Ngelangel C; Whisenant JG; Choueiri TK; Dimopoulou G; Pradervand S; Arnold D; Harrington K; Michielin O; Dafni U; Pentheroudakis G; Peters S; Romano E
ESMO Open; 2022 Jun; 7(3):100499. PubMed ID: 35644101
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.
Murthy S; Archambault PM; Atique A; Carrier FM; Cheng MP; Codan C; Daneman N; Dechert W; Douglas S; Fiest KM; Fowler R; Goco G; Gu Y; Guerguerian AM; Hall R; Hsu JM; Joffe A; Jouvet P; Kelly L; Kho ME; Kruisselbrink RJ; Kumar D; Kutsogiannis DJ; Lamontagne F; Lee TC; Menon K; O'Grady H; O'Hearn K; Ovakim DH; Pharand SG; Pitre T; Reel R; Reeve B; Rewa O; Richardson D; Rishu A; Sandhu G; Sarfo-Mensah S; Shadowitz E; Sligl W; Solomon J; Stelfox HT; Swanson A; Tessier-Grenier H; Tsang JLY; Wood G;
CMAJ Open; 2021; 9(1):E181-E188. PubMed ID: 33688026
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology and public health response in early phase of COVID-19 pandemic, Veneto Region, Italy, 21 February to 2 April 2020.
Russo F; Pitter G; Da Re F; Tonon M; Avossa F; Bellio S; Fedeli U; Gubian L; Monetti D; Saia M; Zanella F; Zorzi M; Narne E; Mantoan D
Euro Surveill; 2020 Nov; 25(47):. PubMed ID: 33243356
[TBL] [Abstract][Full Text] [Related]
26. Detection of severe acute respiratory syndrome coronavirus 2 in nasopharynx according to clinical phenotype of affected patients.
Valent F; Di Chiara A
Clin Microbiol Infect; 2020 Dec; 26(12):1686.e1-1686.e4. PubMed ID: 32905833
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 / COVID-19 in patients on the Swiss national transplant waiting list.
Benden C; Haile S; Kruegel N; Beyeler F; Aubert JD; Binet I; Golshayan D; Hadaya K; Mueller T; Parvex P; Immer F
Swiss Med Wkly; 2020 Dec; 150():w20451. PubMed ID: 33382903
[TBL] [Abstract][Full Text] [Related]
28. Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy.
Serraino D; Zucchetto A; Dal Maso L; Del Zotto S; Taboga F; Clagnan E; Fratino L; Tosolini F; Burba I
Cancer Med; 2021 Nov; 10(21):7781-7792. PubMed ID: 34551210
[TBL] [Abstract][Full Text] [Related]
29. Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry.
De Silvestro G; Marson P; La Raja M; Cattelan AM; Guarnieri G; Monticelli J; Tiberio I; Vianello A; Gandini G; Gessoni G; Fiorin F; Sardella C; Astolfi L; Saia M;
Eur J Intern Med; 2022 Mar; 97():42-49. PubMed ID: 34980505
[TBL] [Abstract][Full Text] [Related]
30. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
[TBL] [Abstract][Full Text] [Related]
31. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
32. Predictors of Intensive Care Unit Admission among Hospitalized COVID-19 Patients in a Large University Hospital in Tehran, Iran.
Hatami H; Soleimantabar H; Ghasemian M; Delbari N; Aryannezhad S
J Res Health Sci; 2021 Feb; 21(1):e00510. PubMed ID: 34024768
[TBL] [Abstract][Full Text] [Related]
33. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
34. Regional COVID-19 Network for Coordination of SARS-CoV-2 outbreak in Veneto, Italy.
Pasin L; Sella N; Correale C; Boscolo A; Rosi P; Saia M; Mantoan D; Navalesi P
J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2341-2345. PubMed ID: 32425461
[No Abstract] [Full Text] [Related]
35. Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients.
Basse C; Diakite S; Servois V; Frelaut M; Noret A; Bellesoeur A; Moreau P; Massiani MA; Bouyer AS; Vuagnat P; Malak S; Bidard FC; Vanjak D; Kriegel I; Burnod A; Bilger G; Ramtohul T; Dhonneur G; Bouleuc C; Cassoux N; ; Paoletti X; Bozec L; Cottu P
JNCI Cancer Spectr; 2021 Feb; 5(1):pkaa090. PubMed ID: 33604509
[TBL] [Abstract][Full Text] [Related]
36. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry.
Borno HT; Kim MO; Hong JC; Yousefi S; Lin A; Tolstykh I; Zhang S; McKay RR; Harismendy O; Cinar P; Rugo H; Koshkin VS; Rabow M; Wang C; Bailey A; Small EJ
Oncologist; 2022 May; 27(5):398-406. PubMed ID: 35348771
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil.
Sansone NMS; Pereira LR; Boschiero MN; Valencise FE; Fraga AMA; Marson FAL
Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35897265
[TBL] [Abstract][Full Text] [Related]
39. Rate of Decompensation of Normoxic Emergency Department Patients with SARS-CoV-2.
Schreyer KE; Isenberg DL; Satz WA; Lucas NV; Rosenbaum J; Zandrow G; Gentile NT
West J Emerg Med; 2021 Apr; 22(3):580-586. PubMed ID: 34125030
[TBL] [Abstract][Full Text] [Related]
40. National outcomes and characteristics of patients admitted to Swedish intensive care units for COVID-19: A registry-based cohort study.
Chew MS; Blixt PJ; Åhman R; Engerström L; Andersson H; Berggren RK; Tegnell A; McIntyre S
Eur J Anaesthesiol; 2021 Apr; 38(4):335-343. PubMed ID: 33534266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
